Foresite Capital Management V, LLC 13F holdings
Foresite Capital Management V, LLC reported 9 positions with a total reported value of $362.2M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: ALMS ALUMIS INC. (45.8%), CGON CG Oncology, Inc. (21.2%), IRON Disc Medicine, Inc. (7.6%), HIMS Hims & Hers Health, Inc. (7.1%), PHVS Pharvaris N.V. (6.3%). Against 2026-03-31 it opened 1 new position and exited 1. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Foresite Capital Management V, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
9 largest of 9 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| ALMS ALUMIS INC. | 5,896,995 | $165.9M | 45.8% |
| CGON CG Oncology, Inc. | 1,079,050 | $76.7M | 21.2% |
| IRON Disc Medicine, Inc. | 374,069 | $27.4M | 7.6% |
| HIMS Hims & Hers Health, Inc. | 738,151 | $25.6M | 7.1% |
| PHVS Pharvaris N.V. | 664,142 | $23.0M | 6.3% |
| EIKN Eikon Therapeutics, Inc. | 1,318,983 | $17.2M | 4.8% |
| ODTX Odyssey Therapeutics, Inc. | 713,105 | $13.3M | 3.7% |
| LYEL Lyell Immunopharma, Inc. | 476,386 | $6.7M | 1.8% |
| NRIX Nurix Therapeutics, Inc. | 265,000 | $6.4M | 1.8% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| ODTX Odyssey Therapeutics, Inc. | 713,105 | $13.3M | 3.7% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 1 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| MAZE Maze Therapeutics, Inc. | 25,905 | $773.3K | 0.3% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| PHVS Pharvaris N.V. | 194,125 | 664,142 | +242.1% | $23.0M |
| CGON CG Oncology, Inc. | 1,004,050 | 1,079,050 | +7.5% | $76.7M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| LYEL Lyell Immunopharma, Inc. | 477,078 | 476,386 | -0.1% | $6.7M |
CIK 1792206 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
